Please login to the form below

Not currently logged in


This page shows the latest Cubist news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 12 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • A rare talent A rare talent

    Unconventionally experienced. Sebastian joined Shire from Cubist, whose commercial operations for the UK, Ireland and Nordics he established to launch two novel antibiotics.

  • Pharma deals in February 2015 Pharma deals in February 2015

    platform. This has been rewarded over the years by a string of research alliances with companies including AstraZeneca, MedImmune, Novartis, Takeda and Cubist (now Merck &Co), as well as an extensive

  • Curbing the rise of drug resistance Curbing the rise of drug resistance

    The KPMG report urges governments and global life sciences businesses to invest more in antibiotic research and development, yet, the recent acquisition of Cubist Pharmaceuticals by Merck &Co.

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    Patrick Vink on Cubist Pharmaceuticals’ ambitions in anti-infectives, which have attracted the attention of Merck &Co. ... Cubicin (daptomycin) is Cubist's leading product with net revenues of $256.7m for the third quarter of 2014.

  • Pharma deals during December 2014 Pharma deals during December 2014

    Cubist itself has been growing over the last few years with a number of acquisitions. ... Under this ruling, four out of five Cubist patents protecting Cubicin were invalidated.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....